NCT03647709

Brief Summary

To prove that total knee arthroplasty can be performed with little, if any need for opioids by using a combination of patient education, optimized pre-op and post-op pain and recovery protocols. The goal being opioid-free total knee arthroplasty.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2018

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 27, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2020

Completed
12 days until next milestone

Results Posted

Study results publicly available

May 12, 2020

Completed
Last Updated

May 12, 2020

Status Verified

May 1, 2020

Enrollment Period

1.1 years

First QC Date

August 9, 2018

Results QC Date

January 24, 2020

Last Update Submit

May 11, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of Patients With Total Knee Replacement Performed Without Opioids Through 12 Weeks Postoperative

    Using a combination of patient education, optimized pre-operative and post-operative pain protocols and optimized recovery protocols

    12 weeks

  • Number of Patients With Total Knee Arthroplasty Performed With Opiate Drugs Through 12 Weeks Postoperative

    The total number of opioid tablets taken by patient after total knee arthroplasty performed through 12 weeks postoperative

    12 weeks

Secondary Outcomes (7)

  • Comparison of Change in Patient's Pain After Surgery At Various Time Intervals When Patient is at Rest and With Activity

    postoperative days 1,2,3,postoperative day 10-14, 3 weeks post surgery, 6 weeks post surgery and 12 weeks post surgery

  • Knee Injury and Osteoarthritis Outcome Score Short Form (KOOS JR)

    Baseline (preoperative); 6 weeks post surgery; 12 weeks post surgery

  • Number of Participants Using Swift Path Educational Tool as Outpatients for Total Joint Replacement

    6 weeks

  • Number of Patients That Adhered to Exercise Protocol After Having Total Knee Arthroplasty - Postop Days 10-14

    Postop Days10-14

  • Number of Patients That Adhered to Exercise Protocol After Having Total Knee Arthroplasty - Postop Week 3

    postoperative 3 weeks

  • +2 more secondary outcomes

Interventions

opioidsOTHER

dosage frequency and duration

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A Partial and total knee arthroplasty Unilateral only

You may qualify if:

  • Surgeries to be performed at hospital
  • Surgeries to be performed at surgery center
  • Ability to read and understand English
  • Primary care clearance for patients diagnosed with high blood pressure

You may not qualify if:

  • Disease states, patient conditions to exclude:
  • Schizophrenia Bipolar Disease Dementia
  • Known allergies to local anesthetics
  • Previous burn to affected extremity
  • BMI \> 40
  • Nonoptimized anemia
  • Albumin less than 3.5
  • A1C \> 8.0

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Elizabeth Medical Center

Utica, New York, 13501, United States

Location

MeSH Terms

Interventions

Analgesics, Opioid

Intervention Hierarchy (Ancestors)

NarcoticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesAnalgesicsSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic Uses

Results Point of Contact

Title
Dr Andrew Wickline
Organization
St Elizabeth Medical Center

Study Officials

  • Andrew B Wickline, MD

    St Elizabeth Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopedic Surgeon

Study Record Dates

First Submitted

August 9, 2018

First Posted

August 27, 2018

Study Start

October 1, 2018

Primary Completion

October 30, 2019

Study Completion

April 30, 2020

Last Updated

May 12, 2020

Results First Posted

May 12, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations